Italy marked a significant milestone at Web Summit Qatar 2026 with its first ever institutional participation, underscoring ...

Gardiner argues that the pharmaceutical and biotech industries must support early, hands-on exposure to demystify complex ...

Dr. Stacy Lindborg is president and CEO of IMUNON, a clinical-stage company in phase 3 development with a lead DNA-mediated immunotherapy for advanced ovarian cancer. Dr. Lindborg has worked in the ...

BRISTOL, TN / ACCESS Newswire / February 4, 2026 / Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) shareholders approved a transformational merger that converts a clinical-stage biopharmaceutical co ...

National Institutes of Health Director Jayanta Bhattacharya, M.D., Ph.D., spent much of a Senate committee hearing dancing around direct answers—except when it came to vaccines, a topic in which he ...

A research team led by La Trobe University has developed a single-use test strip that could ultimately change how diseases ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

Gene therapy is a medical treatment that works by changing or fixing a person's genes to treat or prevent disease ...

A Chicago doctor is using new FDA-approved technology that makes cancer cells glow during surgery. Here's how it works.

The Future X (formerly the Transformation Zone) serves as WHX’s platform for discussing and showcasing innovations in health.

Aprea Therapeutics, Inc. (Nasdaq: APRE) ("Aprea" or the "Company"), a clinical-stage biopharmaceutical company developing innovative therapies that ...

SanegeneBio and Genentech entered a global licensing agreement aimed at advancing an RNA interference (RNAi) therapeutic program, underscoring continued pharmaceutical interest in genetic medicines ...